Generating cash is essential for any business, but not all cash-rich companies are great investments.
Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the data analytics industry, including Health Catalyst (NASDAQ:HCAT) and its peers.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Domo (NASDAQ:DOMO) and the rest of the data analytics stocks fared in Q4.
Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital.
The select few that can do all three for many years are often the ones that make you life-changing money.
Stocks continued to be under pressure on concerns over tariffs and growing inflation concerns, but history shows that corrections can set up opportunities
Samsara is down 45% despite strong earnings and bullish ratings. An RSI of 18 suggests extreme oversold conditions, making this a rare buying opportunity.
Shares of internet of Things company Samsara (NYSE:IOT) fell 14% in the morning session after the company reported weak fourth quarter results: its billings missed, and its full-year revenue guidance only met expectations. On the other hand, Samsara's optimistic full-year EPS guidance blew past analysts' expectations. In addition, its revenue, EPS, and EBITDA outperformed Wall Street's estimates. Overall, this quarter had some key positives. The stock's reaction suggested markets focused on the negative aspect.
The top- and bottom-line results exceeded the high end of the guidance issued in early December, but the topline growth decelerated notably from the previous quarter’s 36% growth.
Internet of Things company Samsara (NYSE:IOT) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 25.3% year on year to $346.3 million. On the other hand, next quarter’s revenue guidance of $351 million was less impressive, coming in 0.6% below analysts’ estimates. Its non-GAAP profit of $0.11 per share was 55.7% above analysts’ consensus estimates.
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
